{
    "2020-08-28": [
        [
            {
                "time": "",
                "original_text": "安信证券：医美业务改善明显，护肤品业务驱动高增，维持华熙生物买入评级",
                "features": {
                    "keywords": [
                        "医美业务",
                        "护肤品业务",
                        "华熙生物",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美",
                        "护肤品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "12张图纵览外资A股持仓，高盛、小摩、领航重仓名单全披露",
                "features": {
                    "keywords": [
                        "外资A股",
                        "高盛",
                        "小摩",
                        "领航",
                        "重仓名单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "电鳗财经|疫情冲击之下，为什么华熙生物能逆势增长？",
                "features": {
                    "keywords": [
                        "疫情冲击",
                        "华熙生物",
                        "逆势增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美",
                        "护肤品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华熙生物增收不增利线上推广费用激增，供应商成竞争对手后续如何？| 中报季 盈利能力下降",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "增收不增利",
                        "推广费用",
                        "供应商",
                        "竞争对⼿",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美",
                        "护肤品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}